4 Results for "

HPK1-IN-7

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "HPK1-IN-7" in MCE Product Catalog:

Cat. No.: HY-138742
CAS No.: 2320462-65-3
Purity:  99.33%
Target:  

MAP4K

Research Areas:  

Cancer

HPK1-IN-7 is a potent, orally active HPK1 (hematopoietic progenitor kinase 1, MAP4K1) inhibitor (IC50=2.6 nM) with excellent family and kinome selectivity. HPK1-IN-7 shows selectivity against IRAK4 (59 nM) and GLK (140 nM). HPK1-IN-7 shows robust efficacy against MC38 syngeneic tumor model in combination with anti-PD1 .
loading...
    loading...
Cat. No.: HY-179727
PROTAC HPK1 Degrader-7 (compound D02) is a potent and selective PROTAC HPK1 degrader with an DC50 of 3.07 nM. PROTAC HPK1 Degrader-7 exhibits selectivity over GLK. PROTAC HPK1 Degrader-7 induces HPK1 degradation in a CRBN- and proteasome-dependent manner. PROTAC HPK1 Degrader-7 inhibits SLP-76 phosphorylation, induces IL-2 and IFN-γ secretion in human primary T cells. PROTAC HPK1 Degrader-7 can be used for immunology research .
loading...
    loading...
Cat. No.: HY-179730
CAS No.: 1543013-96-2
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

CRBN ligand-190 is a is a CRBN-type E3 ubiquitin ligase ligand, can be used for the synthesis of PROTACs, such as PROTAC HPK1 Degrader-7 (HY-179727) .
loading...
    loading...
Cat. No.: HY-179731
Research Areas:  

Cancer

HPK1-IN-67, a HPK1 inhibitor, is a ligand for target protein for PROTAC. HPK1-IN-67 can be used for synthesis of PROTACs, such as PROTAC HPK1 Degrader-7 (HY-179727) .
loading...
    loading...